Nxera Pharma Co., Ltd. (SOLTF)
5.44
0.00 (0.00%)
USD |
OTCM |
Mar 04, 16:00
Nxera Pharma Cash from Investing (Quarterly) : 11.73M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PeptiDream Inc. | -1.283M |
| Stemcell Holdings, Inc. | -- |
| Healios KK | -2.102M |
| AnGes, Inc. | -- |
| SanBio Co., Ltd. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.0675M |
| Cash from Financing (Quarterly) | -69.95M |
| Free Cash Flow | -21.37M |
| Free Cash Flow Per Share (Quarterly) | -0.2311 |
| Free Cash Flow to Equity (Quarterly) | 60.44M |
| Free Cash Flow to Firm (Quarterly) | 34.58M |
| Free Cash Flow Yield | -4.36% |